ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 279 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,698,523 | +42.1% | 81,503 | -3.9% | 0.02% | -45.2% |
| Q2 2022 | $1,195,000 | +11.2% | 84,833 | +84.2% | 0.03% | +72.2% |
| Q4 2021 | $1,075,000 | +188.2% | 46,063 | +104.9% | 0.02% | +200.0% |
| Q3 2021 | $373,000 | -55.7% | 22,483 | -31.1% | 0.01% | -64.7% |
| Q1 2021 | $842,000 | +267.7% | 32,635 | +663.4% | 0.02% | +183.3% |
| Q4 2020 | $229,000 | +10.6% | 4,275 | +0.3% | 0.01% | -40.0% |
| Q2 2020 | $207,000 | -89.2% | 4,264 | -90.5% | 0.01% | -88.4% |
| Q4 2019 | $1,916,000 | -60.7% | 44,793 | -66.9% | 0.09% | -48.5% |
| Q3 2019 | $4,872,000 | +377.6% | 135,365 | +114.6% | 0.17% | +735.0% |
| Q4 2018 | $1,020,000 | -23.8% | 63,082 | -28.1% | 0.02% | -57.4% |
| Q2 2018 | $1,339,000 | -14.3% | 87,705 | +69.1% | 0.05% | +17.5% |
| Q4 2017 | $1,562,000 | +232.3% | 51,869 | +207.9% | 0.04% | +185.7% |
| Q2 2017 | $470,000 | -8.6% | 16,847 | +17.0% | 0.01% | 0.0% |
| Q4 2015 | $514,000 | +1.4% | 14,405 | -6.0% | 0.01% | -17.6% |
| Q3 2015 | $507,000 | -36.1% | 15,327 | -19.2% | 0.02% | -26.1% |
| Q2 2015 | $794,000 | +198.5% | 18,969 | +76.5% | 0.02% | +130.0% |
| Q3 2014 | $266,000 | – | 10,748 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
| SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
| HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
| Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
| GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
| EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
| Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
| Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |